Novel Biomarkers Catalyst Lab (NBCL)

NBCL is dedicated to the development and commercialization of novel biomarker-based assays that could become important diagnostic tools in clinical management. NBCL has extensive development experience across a broad array of immunoassay technology platforms, and our team is committed to rapidly delivering market-ready assays to our customers.

Please contact NBCL to discuss how our immunoassay development expertise might help you.


This website uses cookies to measure the visit, we store NO personal information.